thallium has been researched along with Idiopathic Parkinson Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, KS; Gopalakrishnan, AV; Iyer, M; Raj, N; Suriyanarayanan, A; Vellingiri, B; Venkatesan, D | 1 |
| Amalric, M; Blobaum, AL; Bode, J; Bridges, TM; Bubser, M; Conn, PJ; Daniels, JS; Dickerson, JW; Engers, DW; Hopkins, CR; Italiano, K; Jadhav, S; Jones, CK; Lindsley, CW; Morrison, RD; Niswender, CM; Thompson, AD; Turle-Lorenzo, N | 1 |
| GOTTWALD, W | 1 |
| Bahiga, LM; El-Dessoukey, EA; Kotb, NA | 1 |
2 review(s) available for thallium and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Influence of heavy metals in Parkinson's disease: an overview.
Topics: alpha-Synuclein; Chromium; Cobalt; Humans; Mercury; Metals, Heavy; Nickel; Parkinson Disease; Thallium | 2022 |
Neurological syndromes produced by some toxic metals encountered industrially or environmentally.
Topics: Adult; Arsenic Poisoning; Brain Diseases; Cerebellar Diseases; Child; Environmental Exposure; Humans; Lead Poisoning; Manganese Poisoning; Mental Disorders; Mercury Poisoning; Nervous System Diseases; Occupational Diseases; Optic Neuritis; Organomercury Compounds; Organophosphate Poisoning; Parkinson Disease; Poisoning; Tetraethyl Lead; Thallium | 1978 |
2 other study(ies) available for thallium and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine A2 Receptor Antagonists; Animals; Brain; Calcium Signaling; Catalepsy; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Glutamic Acid; Haloperidol; HEK293 Cells; Humans; Levodopa; Male; Monoamine Oxidase; Motor Neuron Disease; Oxidopamine; Parkinson Disease; Picolinic Acids; Protein Binding; Psychomotor Performance; Pyrimidines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reaction Time; Receptors, G-Protein-Coupled; Receptors, Metabotropic Glutamate; Substantia Nigra; Thallium; Transfection; Triazoles; Tyrosine 3-Monooxygenase | 2012 |
[Midbrain symptoms, Parkinson syndrome and arrest of cerebral convulsive seizures in thallium poisoning].
Topics: Disease; Epilepsy; Heavy Metal Poisoning; Humans; Mesencephalon; Metals, Heavy; Parkinson Disease; Poisoning; Seizures; Thallium | 1957 |